课题基金 / 基金详情

A PHASE III, RANDOMIZED TRIAL OF THE SAFETY AND ANTIRETROVIRAL EFFECTS OF ZID

A PHASE III, RANDOMIZED TRIAL OF THE SAFETY AND ANTIRETROVIRAL EFFECTS OF ZID
ZID 安全性和抗逆转录病毒作用的 III 期随机试验
批准号：
7716700
负责人：
ALICE STEK
金额：
$1.27万
依托单位：
UNIVERSITY OF SOUTHERN CALIFORNIA
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
项目状态：
已结题
起止时间：
2008-04-20 至 2008-11-30
来源：
https://reporter.nih.gov/project-details/7716700
关键词：
Anti-Retroviral AgentsComputer Retrieval of Information on Scientific Projects DatabaseFundingGrantInstitutionLamivudine/ZidovudineLopinavir/RitonavirPatient currently pregnantPhaseRandomized Controlled Clinical TrialsResearchResearch PersonnelResourcesSafetySourceStandards of Weights and MeasuresTreatment ProtocolsUnited States National Institutes of HealthWomanZidovudineabacavirdesign

项目摘要

项目成果

ALICE STEK的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 PACTG P1039是专门为那些计划仅在怀孕时服用抗逆转录病毒药物的妇女设计的，如果没有怀孕，目前不符合开始治疗的标准。这项研究将比较All NRTI方案(阿巴卡韦/拉米夫定/齐多夫定)和标准PI方案(洛匹那韦/利托那韦和拉夫定/齐多夫定)。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. PACTG P1039 is designed expressly for women who plan to take antiretrovirals only when pregnant and do not currently meet criteria for initiation of treatment if not pregnant. This study will compare an all NRTI regimen (abacavir/lamivudine/zidovudine) with a standard PI containing regimen (lopinavir/ritonavir and lamvudine/zidovudine).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PERINATAL CORE PROTOCOL (PACTG P1025) (HIV)
PHARMACOKINETIC PROPERTIES OF ANTIRETROVIRAL THERAPY DURING PREGNANCY (PACTG)
PERINATAL CORE PROTOCOL (PACTG P1025) (HIV)
PHARMACOKINETIC PROPERTIES OF ANTIRETROVIRAL THERAPY DURING PREGNANCY (PACTG)